Longeveron Reports Third Quarter Financial Results Missing Earnings and Revenue Estimates
Longeveron (LGVN) has reported its third-quarter financial results, revealing a significant miss on both the top and bottom lines. The company posted a GAAP earnings per share (EPS) of -$1.91, falling short of analyst expectations by $0.21. Revenue for the quarter reached only $0.12 million, missing consensus estimates by $0.68 million. These results reflect continued heavy spending and minimal commercial activity as the biotechnology firm progresses through its clinical development stages.
Topics: EPS miss quarterly earnings revenue miss